The above observations indicate that IGF1R has immuno-modulatory potential and that its targeting may be exploited to potentiate the intrinsic anti-cancer activity of the immune system and could be used in combination with different immunotherapeutic agents to improve cancer treatment. Here, IGF1R is linked to cancer.